Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
On Oct. 16, 2026, HCA is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
Hca Healthcare, Inc. is a large-cap company with a market capitalization of $106.90B. It ranks number 1 by market capitalization among the 6 Services-General Medical & Surgical Hospitals, NEC issuers in our coverage with a current forecast.
For HCA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 10.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.7%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, HCA included.
Follow HCA free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-General Medical & Surgical Hospitals, NEC peers listed below that report each metric.
| Metric | HCA | Rank |
|---|---|---|
| Market Cap | $106.90B | 1/6 |
| P/E Ratio | 16.14x | 2/5 |
| Dividend Yield | 0.64% | – |
| EPS | $29.03 | – |
| Revenue/Share | $334.76 | – |
| FCF/Share | $34.74 | – |
| Metric | HCA | Rank |
|---|---|---|
| ROA | 11.1% | 1/5 |
| Net Margin | 8.9% | 1/6 |
| EBT Margin | 12.8% | 2/6 |
| Tax Rate | 20.2% | – |
| Metric | HCA | Rank |
|---|---|---|
| Current Ratio | 0.83x | 6/6 |
| Quick Ratio | 0.75x | – |
| Working Capital | -$3.21B | 6/6 |
| Metric | HCA | Rank |
|---|---|---|
| Operating Cash Flow | $13.00B | 1/6 |
| Free Cash Flow | $7.93B | 1/5 |
| Capital Spending | -$5.07B | 5/5 |
| OCF Growth YoY | 34.1% | 3/6 |
| FCF Growth YoY | 60.2% | 2/5 |
| FCF/Sales | 10.4% | 2/5 |
| CapEx/Sales | 6.6% | 1/5 |
| Metric | HCA | Rank |
|---|---|---|
| Asset Turnover | 1.24x | 1/5 |
| Receivables Turnover | 6.8x | 3/6 |
| Fixed Assets Turnover | 2.4x | 6/6 |
| Days Sales Outstanding | 54 days | 4/6 |
| Metric | HCA | Rank |
|---|---|---|
| Total Revenue | $76.39B | 1/6 |
| Net Income | $6.79B | 1/6 |
| Metric | HCA | Rank |
|---|---|---|
| Dividends Per Share | $2.99 | – |
| Payout Ratio | 10.3% | – |
| Shares Outstanding | 228M | – |
| Net Income Growth | 17.6% | – |
| EPS Growth | 28.9% | – |
| Total Current Assets | $16.05B | |
| Cash & Short-term Investments | $940M | |
| Accounts Receivable | $11.32B | |
| Inventory | $1.68B | |
| Total Liabilities | $64.43B | |
| Short-term Debt | $14.45B |
Companies classified under the same SEC industry code as Hca Healthcare, Inc. (Services-General Medical & Surgical Hospitals, NEC): 6 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeHCA Healthcare, Inc. (HCA), headquartered in Nashville, Tennessee, owns and operates hospitals and related healthcare entities. Valued at $92.4 billion by market cap, the company provides diagnosis, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
HCA Healthcare is a Buy supported by strong revenue growth and favorable demographic trends in healthcare demand. Read more ...
On Oct. 16, 2026, HCA is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
For HCA, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 10.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 14.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Hca Healthcare, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
6 issuers in our coverage, HCA included, share the SEC industry code Services-General Medical & Surgical Hospitals, NEC. The largest are: Tenet Healthcare Corp (THC), Universal Health Services Inc (UHS), Surgery Partners, Inc. (SGRY), Ardent Health, Inc. (ARDT), Community Health Systems Inc (CYH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.